Seeking Alpha

Insulet (PODD +2.7%), a maker of insulin infusion devices for diabetics, is trading higher...

Insulet (PODD +2.7%), a maker of insulin infusion devices for diabetics, is trading higher thanks to a bullish note from Barrington. While noting Insulet's recent Q4 report missed estimates, the firm still expects Insulet's OmniPod pump to act as a positive catalyst for shares.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector

Next headline on your portfolio:

|